
Andrea Necchi/LinkedIn
Jul 31, 2025, 13:20
Andrea Necchi: An Important Day for Patients with Bladder Cancer
Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared on LinkedIn:
“Today marks an important day for patients with bladder cancer.
84% CR rate with TAR200 monotherapy in BCG unresponsive CIS
Sunrise1
FDA Priority Review
Here is the Journal of Clinical Oncology paper supporting these results.”
More posts featuring Bladder Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 31, 2025, 13:20
Jul 31, 2025, 13:01
Jul 31, 2025, 12:59
Jul 31, 2025, 12:53
Jul 31, 2025, 12:31
Jul 31, 2025, 12:25
Jul 31, 2025, 12:21
Jul 31, 2025, 12:19